Startup Intelligence Platform
Vida Ventures is a life sciences venture capital firm dedicated to funding and developing innovative medical breakthroughs that aim to significantly improve patient outcomes. Founded in 2017 by a group of scientists, physicians, entrepreneurs, and investors, the firm has a bicoastal presence with offices in Boston, Massachusetts, and San Francisco, California. Vida Ventures manages approximately $1.7 billion in assets across its funds, including Vida Ventures III, which closed in July 2021 with $825 million. The firm's portfolio includes companies such as Allogene Therapeutics, Kronos Bio, and Homology Medicines, reflecting its commitment to advancing transformative biomedical innovations. Vida Ventures focuses on a flexible investment approach, supporting companies at various stages and across therapeutic areas, with a particular emphasis on therapeutics. The firm's mission is to bring science to life by advancing biomedical innovations that have the potential to make a meaningful difference in patients' lives.